Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience

Affiliations

• ¹ Department of General Pediatrics and Center for Rare Diseases, Muenster University Children's Hospital, Muenster, Germany. [email protected].
• ² Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
• ³ Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.